Skip to main content
. 2020 Jul 30;11(7):605. doi: 10.1038/s41419-020-02807-0

Fig. 7. Administration of the JAK1 inhibitor, baricitinib, inhibits HepG2 and Huh-7 cell proliferation.

Fig. 7

TNM3 silencing reduces proliferation of SW579 cells. Cells were incubated with 2 μM baricitinib or 1% DMSO for 1 h. a, b Western blot analyses showing JAK1 and STAT3 expression, and STAT3 phosphorylation in HepG2 and Huh-7 cells, following incubation with baricitinib or DMSO. c, d Immunofluorescence assay showing the cellular localization of STAT3 in cells after incubation with baricitinib or DMSO. e, f Colony formation assay indicating HepG2 and Huh-7 growth rates, with baricitinib or DMSO treatment. g, h FCM evaluation of HepG2 and Huh-7 cell apoptosis with baricitinib or DMSO treatment. *p < 0.05 vs. indicated groups.